Literature DB >> 2181307

Structural diversity in the 45-kilodalton merozoite surface antigen of Plasmodium falciparum.

J A Smythe1, M G Peterson, R L Coppel, A J Saul, D J Kemp, R F Anders.   

Abstract

An integral membrane protein associated with the merozoite surface of Plasmodium falciparum termed merozoite surface antigen 2 (the 45-kDa merozoite surface antigen), occurs in antigenically diverse forms. Here we report the sequences of the MSA 2 gene from two other isolates of P. falciparum. The 43 N-terminal residues and the 74 C-terminal residues of all three MSA 2 sequences are highly conserved, but between these conserved regions there are dramatic differences among the alleles. Instead of the two copies of a 32-amino-acid repeat present in the MSA 2 of isolate FC27, MSA 2 from clone 3D7 and isolate Indochina 1 contain 5 and 12 copies respectively of the four amino acid sequence Gly Gly Ser Ala. The sequences flanking the repeats also differ among the three antigens. The repeats in MSA 2 appear to be immunodominant during natural infection, and antibodies to the repeat regions of different alleles react with a restricted number of parasite isolates.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2181307     DOI: 10.1016/0166-6851(90)90061-p

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  52 in total

1.  Structural and antigenic properties of merozoite surface protein 4 of Plasmodium falciparum.

Authors:  L Wang; C G Black; V M Marshall; R L Coppel
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Longitudinal study of Plasmodium falciparum polymorphic antigens in a malaria-endemic population.

Authors:  D J Conway; B M Greenwood; J S McBride
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

3.  Capture of chromosomal DNA by anti-histone antibodies for PCR.

Authors:  A M Lew; J Kelly
Journal:  Nucleic Acids Res       Date:  1991-06-25       Impact factor: 16.971

4.  Strain-transcending Fc-dependent killing of Plasmodium falciparum by merozoite surface protein 2 allele-specific human antibodies.

Authors:  Janine Stubbs; Sope Olugbile; Balam Saidou; Jacques Simpore; Giampietro Corradin; Antonio Lanzavecchia
Journal:  Infect Immun       Date:  2010-12-28       Impact factor: 3.441

5.  Solution conformation, backbone dynamics and lipid interactions of the intrinsically unstructured malaria surface protein MSP2.

Authors:  Xuecheng Zhang; Matthew A Perugini; Shenggen Yao; Christopher G Adda; Vincent J Murphy; Andrew Low; Robin F Anders; Raymond S Norton
Journal:  J Mol Biol       Date:  2008-03-28       Impact factor: 5.469

6.  Structural and antigenic polymorphism of the 35- to 48-kilodalton merozoite surface antigen (MSA-2) of the malaria parasite Plasmodium falciparum.

Authors:  B Fenton; J T Clark; C M Khan; J V Robinson; D Walliker; R Ridley; J G Scaife; J S McBride
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

7.  A primary malarial infection is composed of a very wide range of genetically diverse but related parasites.

Authors:  P Druilhe; P Daubersies; J Patarapotikul; C Gentil; L Chene; T Chongsuphajaisiddhi; S Mellouk; G Langsley
Journal:  J Clin Invest       Date:  1998-05-01       Impact factor: 14.808

8.  Genetic polymorphism and natural selection in the malaria parasite Plasmodium falciparum.

Authors:  A A Escalante; A A Lal; F J Ayala
Journal:  Genetics       Date:  1998-05       Impact factor: 4.562

9.  Serum antibody immunoglobulin G of mice convalescent from Plasmodium yoelii infection inhibits growth of Plasmodium falciparum in vitro: blood stage antigens of P. falciparum involved in interspecies cross-reactive inhibition of parasite growth.

Authors:  P Ray; N Sahoo; B Singh; F A Kironde
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

10.  Human antibody response to Plasmodium falciparum merozoite surface protein 2 is serogroup specific and predominantly of the immunoglobulin G3 subclass.

Authors:  R R Taylor; D B Smith; V J Robinson; J S McBride; E M Riley
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.